Latest SUMO protein Stories
Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma.
A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain.
When SUMO grips STAT5, a protein that activates genes, it blocks the healthy embryonic development of immune B cells and T cells unless its nemesis breaks the hold.
A small protein called SUMO might prevent the protein aggregations that typify Parkinson's disease (PD).
A small protein called SUMO might prevent the protein aggregations that typify Parkinson's disease (PD), according to this study.
A team of investigators led by a physician-scientist at The University of Texas MD Anderson Cancer Center has shown for the first time that the small protein SUMO can team up with the replication protein A (RPA) complex to facilitate DNA repair.
New on-off switches: SUMO protein silences developmental genes, SNP2 snips SUMO to allow gene expression